SOPHiA GENETICS SA (SOPH) Análisis de acciones

Descripción de la empresa

SOPHiA GENETICS SA operates as a cloud-native software technology company within the healthcare sector, specifically focusing on Health Information Services. The enterprise provides the SOPHiA DDM platform, a specialized cloud-native software solution designed for analyzing data and generating insights from multimodal data sets and diagnostic modalities. This operational scale is reflected in a total market capitalization of $351.18M, with annual revenue reaching $77.27M over the trailing twelve months and an employee base of 415 individuals. The market cap figure indicates that the company holds a mid-cap position in the specialized health information services industry, while the revenue level suggests a growing operational footprint despite the high capital intensity often associated with software development in healthcare diagnostics.

Salud financiera

The company reported a revenue of $77.27M and an EBITDA of $-69.168M for the trailing twelve months, while the net income stood at $-78,999,000. The significant negative variance between the positive revenue figure and the large negative net income reveals a cost structure where operating expenses, likely driven by research and development or sales acquisition costs, substantially exceed gross profits. Free cash flow for the period was $-16.462M, indicating that the company's current financial flexibility is constrained by capital expenditures or working capital requirements that outpace its cash generation capabilities. The gross margin stands at 67.4%, which is robust for a software platform, yet the operating margin is deeply negative at -85.4%, and the profit margin is -102.2%, highlighting that the company is currently burning cash to scale its platform. The balance sheet shows cash reserves of $70.29M against total debt of $63.02M, resulting in a debt-to-equity ratio of 133.67, which suggests a highly leveraged capital structure relative to shareholders' equity. Despite the leverage, the current ratio of 1.96 indicates that the company possesses sufficient current assets to cover its short-term liabilities nearly twice over, pointing to adequate short-term liquidity management. Furthermore, the return on equity is -110.0% and the return on assets is -27.9%, metrics that reveal management is currently utilizing the company's capital base to generate losses rather than positive returns.

Evaluación de valoración

The trailing twelve-month P/E ratio is not available due to negative earnings, whereas the forward P/E ratio is listed at -8.75, implying that the market is currently pricing the stock based on future expected earnings recovery rather than historical profitability. The price-to-book ratio is 7.12, indicating that the market values the company at more than seven times its book value, which suggests a significant premium assigned to its intangible assets and proprietary technology platform. Alternative valuation metrics such as the price-to-sales ratio of 4.54 and an EV/EBITDA of -4.97 provide context for a growth-stage company where traditional earnings-based multiples are less relevant than revenue-based multiples. The stock's 52-week trading range spans from a low of $2.58 to a high of $5.70, providing a clear band for price volatility analysis. Without the specific current share price provided in the source data to calculate the exact percentage deviation, the valuation metrics combined with the wide 52-week range suggest the stock is sensitive to market sentiment regarding its turnaround potential. The beta value of 1.04 indicates that the stock's price volatility moves in tandem with the broader market, exhibiting slightly higher sensitivity than the average market index.

Growth & Income

Revenue growth year-over-year was recorded at 22.4%, while earnings growth is not applicable due to negative net income, indicating that revenue expansion is currently outpacing any potential earnings recovery. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, the firm retains all generated cash to fund its operations and invest in future growth initiatives rather than distributing income to shareholders. The absence of a dividend payout is consistent with the negative free cash flow and negative net income, as the company prioritizes capital investment to address the high operating expenses and achieve profitability. The overall growth and income profile reflects a classic high-growth, pre-profitability technology company that relies on reinvestment strategies to convert its strong revenue growth into sustainable earnings in the future.